HTB

2022

Understanding HIV and monkeypox coinfection: NEAT/EACS dashboard

HIV seroconversions on PrEP in Australian study are linked to low adherence

BHIVA include efficacy data on HIV and monkeypox vaccine: updated statement

MPX vaccine update – access, doses, safer MPX sex

US guidelines on HIV-related OIs online for comment

HTB August 2022 (3 August 2022)

Sending unused meds to Ukraine: emergency appeal

Organisations to support Ukraine

Taking a break from monkeypox: four weeks out for August

24th International AIDS Conference (AIDS 2022): first reports

Dolutegravir-based ART in children and adolescents: effective in six African countries

Early data on injecting CAB/RPV-LA into thigh muscle

Simplifed lenacapavir dosing: PK results in HIV negative study

Doxycycline PEP significantly reduces STIs in people at high risk of infections

Another possible HIV cure case after stem cell transplantation for cancer; example of extended post-treatment control in Spain

Other cure-related sessions at AIDS 2022

Selected reports launched at AIDS 2022

WHO declares the monkeypox pandemic a global health emergency

UK organisations call for £51 million to urgently tackle monkeypox crisis

EMA approves Imvanex vaccine against monkeypox in EU

International study of 528 monkeypox (MPX) cases: results from the 2022 outbreak need to inform new management guidelines

Tecovirimat to treatment monkeypox: an urgent need for both RCT and expanded access

Monkeypox DNA detected at high levels in saliva and is common in semen and other samples

Risk of monkeypox being infectious on hard surfaces and soft materials: guidelines for effective cleaning

Outcomes of 54 cases of monkeypox (MPX) in London: fewer early symptoms but higher rates of genital lesions – urgency of funding sexual health

Ending the monkeypox outbreak through vaccination, contact tracing and early diagnosis

US doctors think it is already too late to contain monkeypox

Case report of COVID-19 transmission from sneezing cat

Accumulating SARS-CoV-2 mutations in prolonged COVID-19 in advanced HIV off-ART

No benefit from TDF/FTC against COVID-19

HTB: no. 8 (3 August 2022) PDF downloads

HTB July 2022 (1 July 2022) now online

Introduction to ART: i-Base guide (June 2022)

Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride

29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): final report

CROI 2022: NAMSAL study comparing DTG to EFV400 in Cameroon: week 192 results

Lenacapavir gets positive opinion for approval in the EU to treat MDR HIV

Combination bNAb’s sustain viral suppression for 40 weeks: phase 1 results

Dual bNAbs in children: dose-finding and safety data on VRC01LS and 10-1074 in the Tatelo study 

UK offers limited vaccine to gay and bisexual men at risk of monkeypox: full dose offered in NYC

Full results from ANCHOR study published in NEJM

INSTIs and cardiovascular events in the RESPOND cohort: early increase at six months normalises after two years

Gonorrhoea vaccine might halve infections and help combat drug resistance

COVID update: new waves of BA.4 and BA.5 in the UK – all omicron variants linked to reduced antibody responses to vaccines

Importance of booster vaccine to protect against emergent COVID-19 variants

Similar COVID-19 vaccination responses in HIV positive people on ART and with good CD4 counts compared to HIV negative controls

US study reports higher rates of breakthrough COVID in HIV positive vs negative controls

BMJ reports UK government failed to protect doctors during COVID-19

Fantastic voyage: tracking adherence sensors in PrEP meds

UK increases funding to UNAIDS: still dramatically lower than before last years’ 80% cut

HTB: no. 7 (1 July 2022) PDF downloads

HTB June 2022 (1 June 2022)

29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): further reports

CROI 2022: Updates from the VESTED study

CROI 2022: Switching to dolutegravir for adults on stable PI-based second-line ART

Lenacapavir in MDR HIV: phase 3 results of CAPELLA study published

ViiV licenses long-acting cabotegravir (CAB-LA) for generic access

Monkeypox outbreak: Update and further information

Draft BHIVA guidelines online for comment: deadline 9 June

Monkeypox cases in gay men in the UK: BHIVA and ECDC rapid statements

Monkeypox DNA in semen supports advice to use condoms for eight weeks after infection has cleared

Risk of monkeypox becoming endemic in Europe: ECDC assessment

Seven cases of monkeypox virus in the UK from 2018 to 2021

Monkeypox: Q&A factsheet

Implications of SARS-CoV-2 in gut tissue for transmission of COVID-19 and long COVID

Post navigation